Stocks and Investing
Stocks and Investing
Mon, July 12, 2021
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Sat, July 10, 2021
[ 12:00 AM ] - United States, WOPRAI
Fri, July 9, 2021
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Mark Devries Maintained (UWMC) at Buy with Increased Target to $9 on, Jul 9th, 2021
Mark Devries of Barclays, Maintained "UWM Holdings Corporation" (UWMC) at Buy with Increased Target from $8 to $9 on, Jul 9th, 2021.
Mark has made no other calls on UWMC in the last 4 months.
There are 5 other peers that have a rating on UWMC. Out of the 5 peers that are also analyzing UWMC, 4 agree with Mark's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Bose George of "Keefe, Bruyette & Woods" Initiated at Hold and Held Target at $8.5 on, Friday, July 2nd, 2021
- Ryan Carr of "Jefferies" Initiated at Hold and Held Target at $9.5 on, Wednesday, June 23rd, 2021
- Henry Coffey of "Wedbush" Downgraded from Buy to Hold and Increased Target to $10 on, Monday, June 14th, 2021
- Douglas Harter of "Credit Suisse" Downgraded from Buy to Hold and Increased Target to $8.5 on, Wednesday, June 2nd, 2021
This is the rating of the analyst that currently disagrees with Mark
- Kevin Heal of "Argus Research" Initiated at Strong Buy and Held Target at $10 on, Thursday, May 27th, 2021
Contributing Sources